おかえりなさい
アカウント登録
siteでログインする
siteで登録する
受信トレイを確認する
Aderis Pharmaceuticals
About
Aderis Pharmaceuticals focused on discovery, development and commercialization of products for the diagnosis.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series D
- Last Funding Money Raised
- $45M
- Industries
- Biopharma,Biotechnology,Developer Platform,Health Diagnostics
- Founded date
- Jan 1, 1994
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Aderis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovery, development and commercialization of products for the diagnosis and treatment of cardio-renal diseases. Discovery Therapeutics' product pipeline includes adenosine agonists and antagonists for the diagnosis and treatment of cardiovascular disease and leukotriene synthesis inhibitors for the treatment of chronic renal disease. In addition the company has license agreements with strategic partners involving novel late stage products for the treatment of Parkinson's disease and diagnosis of coronary artery disease.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 9, 2001 | Series D | $45M | 2 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series D |
Perseus-Soros Biopharmaceutical Fund
|
— | Series D |
